SI1383507T1 - Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances - Google Patents

Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances

Info

Publication number
SI1383507T1
SI1383507T1 SI200230658T SI200230658T SI1383507T1 SI 1383507 T1 SI1383507 T1 SI 1383507T1 SI 200230658 T SI200230658 T SI 200230658T SI 200230658 T SI200230658 T SI 200230658T SI 1383507 T1 SI1383507 T1 SI 1383507T1
Authority
SI
Slovenia
Prior art keywords
intoxications
galanthamine
pathologies
utilization
treatment
Prior art date
Application number
SI200230658T
Other languages
Slovenian (sl)
Inventor
Klaus Opitz
Joachim Moormann
Thomas Hille
Frank Becher
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10119862A external-priority patent/DE10119862A1/en
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of SI1383507T1 publication Critical patent/SI1383507T1/en

Links

SI200230658T 2001-04-24 2002-04-18 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances SI1383507T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119862A DE10119862A1 (en) 2001-04-24 2001-04-24 Use of galanthamine for the treatment of symptoms of the central nervous system due to intoxications with psychotropic substances
EP02764017A EP1383507B1 (en) 2001-04-24 2002-04-18 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
PCT/EP2002/004277 WO2002085370A1 (en) 2001-04-24 2002-04-18 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances

Publications (1)

Publication Number Publication Date
SI1383507T1 true SI1383507T1 (en) 2008-04-30

Family

ID=39356871

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230658T SI1383507T1 (en) 2001-04-24 2002-04-18 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances

Country Status (1)

Country Link
SI (1) SI1383507T1 (en)

Similar Documents

Publication Publication Date Title
HK1152243A1 (en) Vegf for use in the treatment of central nervous system disorders vegf
EP1434801A4 (en) Treatment for central nervous system disorders
EP1385937A4 (en) Delivery of polynucleotide agents to the central nervous sysstem
IL209842A0 (en) Compounds for the treatment of metabolic disorders
IL176581A0 (en) Immunomodulatory compounds for the treatment of central nervous system disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL155433A0 (en) Treatment of t cell disorders
HUP0401123A3 (en) Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002308148A1 (en) Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
IL152688A0 (en) Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
IL155874A0 (en) Treatment of anxiety disorders
HK1049122A1 (en) The use of mirtazapine for the treatment of sleep disorders
SI1383507T1 (en) Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
IL164951A0 (en) The treatment of pain with lfendropil
AU4838301A (en) Treatment of disorders relating to the serotonergic system
AU2003237841A8 (en) Pain signaling molecules
GB0010496D0 (en) Treatment of conditions of the central nervous system
IL145768A0 (en) Drinkable pharmaceutical solution
GB0102731D0 (en) Apparatus To Demonstrate Behaviour Of Liquids
HUP0303518A3 (en) Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
TW551183U (en) Improved structure of liquid vaporizer